articleOphthalmologyJul 16, 2019HYBRID OA

Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration

Retina Vitreous Associates Medical Group · Apellis Pharmaceuticals (United States) · +12 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Design

Prospective, multicenter, randomized, sham-controlled phase 2 study.

Participants

Two hundred forty-six patients with GA.

No related works found for this paper.